Ozempic Kidney Trial Sinks Dialysis Stocks

Ozempic pens at a Novo Nordisk factory. Novo Nordisk is Europe's most-valuable listed company. (Charlotte de la Fuente for The Wall Street Journal) The weight-loss revolution is shaking another industry. Kidney-dialysis stocks sank Wednesday after Novo Nordisk (NVO), (DK: NOVO.B) said a trial…#novonordisk #charlottedelafuente #nvo #frankfurt #freseniusmedicalcare #xe #fre #fms #dva
Source: Reuters: Health - Category: Consumer Health News Source Type: news